Insider Transactions in Q2 2022 at Ionis Pharmaceuticals Inc (IONS)
Insider Transaction List (Q2 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 10
2022
|
Joan E Herman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,555
+15.38%
|
-
|
Jun 07
2022
|
Spencer R Berthelsen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+8.51%
|
$135,000
$12.94 P/Share
|
Apr 21
2022
|
Eric Swayze EVP Research |
SELL
Open market or private sale
|
Direct |
378
-1.82%
|
$16,632
$44.15 P/Share
|
Apr 18
2022
|
Onaiza Cadoret Manier EVP, Chf GL Pdt Str & Oper Ofc |
SELL
Payment of exercise price or tax liability
|
Direct |
1,960
-13.95%
|
$80,360
$41.01 P/Share
|
Apr 18
2022
|
Onaiza Cadoret Manier EVP, Chf GL Pdt Str & Oper Ofc |
BUY
Exercise of conversion of derivative security
|
Direct |
5,667
+28.74%
|
-
|
Apr 12
2022
|
Patrick R. O'Neil EVP CLO & General Counsel |
SELL
Open market or private sale
|
Direct |
6,792
-16.43%
|
$271,680
$40.06 P/Share
|
Apr 01
2022
|
Brett P Monia Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
355
-0.4%
|
$13,135
$37.49 P/Share
|